CGA and Zollinger-Ellison syndrome: Serum CgA is a sensitive marker in patients with ZES [9,259,304,307,308,309,310,311]; however, numerous studies have shown its usefulness is greatly limited in ZES patients, similarly to other patients with NETs/pNETs, because of its low specificity [305,306,307,312].